BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li D, Luan J, Zhang L. Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors. Biochem Biophys Res Commun 2021;538:72-9. [PMID: 33276953 DOI: 10.1016/j.bbrc.2020.11.083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mathieu NA, Paparisto E, Barr SD, Spratt DE. HERC5 and the ISGylation Pathway: Critical Modulators of the Antiviral Immune Response. Viruses 2021;13:1102. [PMID: 34207696 DOI: 10.3390/v13061102] [Reference Citation Analysis]
2 Arwansyah A, Arif AR, Ramli I, Kurniawan I, Sukarti S, Nur Alam M, Illing I, Farid Lewa A, Manguntungi B. Molecular modelling on SARS-CoV-2 papain-like protease: an integrated study with homology modelling, molecular docking, and molecular dynamics simulations. SAR QSAR Environ Res 2021;32:699-718. [PMID: 34392751 DOI: 10.1080/1062936X.2021.1960601] [Reference Citation Analysis]
3 Ye N, Yang Z, Liu Y. Applications of density functional theory in COVID-19 drug modeling. Drug Discov Today 2021:S1359-6446(21)00568-7. [PMID: 34954327 DOI: 10.1016/j.drudis.2021.12.017] [Reference Citation Analysis]
4 Sanachai K, Mahalapbutr P, Sanghiran Lee V, Rungrotmongkol T, Hannongbua S. In Silico Elucidation of Potent Inhibitors and Rational Drug Design against SARS-CoV-2 Papain-like Protease. J Phys Chem B 2021;125:13644-56. [PMID: 34904832 DOI: 10.1021/acs.jpcb.1c07060] [Reference Citation Analysis]
5 Rehman MFU, Akhter S, Batool AI, Selamoglu Z, Sevindik M, Eman R, Mustaqeem M, Akram MS, Kanwal F, Lu C, Aslam M. Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World. Antibiotics (Basel) 2021;10:1011. [PMID: 34439061 DOI: 10.3390/antibiotics10081011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Moradi M, Golmohammadi R, Najafi A, Moosazadeh Moghaddam M, Fasihi-Ramandi M, Mirnejad R. In Silico Analysis of Inhibiting Papain-like Protease from SARS-CoV-2 by Using Plant-Derived Peptides. Int J Pept Res Ther 2022;28:24. [PMID: 34903959 DOI: 10.1007/s10989-021-10331-8] [Reference Citation Analysis]
7 Verma D, Mitra D, Paul M, Chaudhary P, Kamboj A, Thatoi H, Janmeda P, Jain D, Panneerselvam P, Shrivastav R, Pant K, Das Mohapatra PK. Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/ 3CLpro: molecular docking and simulation studies of three pertinent medicinal plant natural components. Curr Res Pharmacol Drug Discov 2021;2:100038. [PMID: 34870149 DOI: 10.1016/j.crphar.2021.100038] [Reference Citation Analysis]
8 Wang J, Wang C, Shen L, Zhou L, Peng L. Screening Potential Drugs for COVID-19 Based on Bound Nuclear Norm Regularization. Front Genet 2021;12:749256. [PMID: 34691157 DOI: 10.3389/fgene.2021.749256] [Reference Citation Analysis]